Login / Signup

Sequential Whole Exome Sequencing Reveals Somatic Mutations Associated with Platinum Response in NSCLC.

Ao-Xiang GuoFan XiaoWei-Hua ShaoYan ZhanLe ZhangJing XiongYang GaoJi-Ye Yin
Published in: OncoTargets and therapy (2020)
These results support that somatic mutations can affect platinum drug response and provide potential clinical biomarkers for NSCLC treatment.
Keyphrases
  • small cell lung cancer
  • advanced non small cell lung cancer
  • copy number
  • brain metastases
  • emergency department
  • risk assessment
  • gene expression
  • combination therapy
  • human health
  • adverse drug
  • replacement therapy